| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 May 2026 | 19 May 2026 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 at Registered office 38E/252A Vijay Tower 3rd Floor Panchsheel Commercial Complex Shahpur Jat New Delhi-110049 (deemed venue) through video conferencing/Audio visual connection inter alia to consider approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2025-26 and for the Financial year 2025-26 ended on March 31 2026. Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31, 2026 (As per BSE Announcement dated on: 29.05.2026) | ||
| Board Meeting | 6 Feb 2026 | 28 Jan 2026 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on 6th February 2026 to consider interalia un-audited financial results (standalone and consolidated) for the 3rd quarter/9 months ended 31.12.2025 of FY 2025-26 Board at its meeting held today interalia approved Unaudited Financial Results (both standalone and consolidated) for the quarter and nine months ended 31.12.2025 of FY 2025-26 (As Per BSE Announcement Dated on: 06/02/2026) | ||
| Board Meeting | 4 Nov 2025 | 24 Oct 2025 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 inter alia to consider and approve Board Meeting of the Company is scheduled to be held on Tuesday 4th November 2025 to consider interalia the un-audited financial results (standalone and consolidated) of the Company for the quarter/half year ended 30th September 2025. Board of Directors at its meeting held today on 04.11.2025 interalia approved Unaudited Financial results (both standalone and consolidated) for the quarter/half year ended 30.09.2025 (As Per BSE Announcement Dated on: 04/11/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
